These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34839410)

  • 1. Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
    Neumann JM; Freitag H; Hartmann JS; Niehaus K; Galanis M; Griesshammer M; Kellner U; Bednarz H
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):351-360. PubMed ID: 34839410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.
    Kriegsmann M; Casadonte R; Kriegsmann J; Dienemann H; Schirmacher P; Hendrik Kobarg J; Schwamborn K; Stenzinger A; Warth A; Weichert W
    Mol Cell Proteomics; 2016 Oct; 15(10):3081-3089. PubMed ID: 27473201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
    Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging.
    Bensussan AV; Lin J; Guo C; Katz R; Krishnamurthy S; Cressman E; Eberlin LS
    Clin Chem; 2020 Nov; 66(11):1424-1433. PubMed ID: 33141910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens.
    Sigel CS; Moreira AL; Travis WD; Zakowski MF; Thornton RH; Riely GJ; Rekhtman N
    J Thorac Oncol; 2011 Nov; 6(11):1849-56. PubMed ID: 21841504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type.
    Lee GK; Lee HS; Park YS; Lee JH; Lee SC; Lee JH; Lee SJ; Shanta SR; Park HM; Kim HR; Kim IH; Kim YH; Zo JI; Kim KP; Kim HK
    Lung Cancer; 2012 May; 76(2):197-203. PubMed ID: 22099218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
    Kayser G
    Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.
    Rekhtman N; Brandt SM; Sigel CS; Friedlander MA; Riely GJ; Travis WD; Zakowski MF; Moreira AL
    J Thorac Oncol; 2011 Mar; 6(3):451-8. PubMed ID: 21266922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust subtyping of non-small cell lung cancer whole sections through MALDI mass spectrometry imaging.
    Janßen C; Boskamp T; Hauberg-Lotte L; Behrmann J; Deininger SO; Kriegsmann M; Kriegsmann K; Steinbuß G; Winter H; Muley T; Casadonte R; Kriegsmann J; Maaß P
    Proteomics Clin Appl; 2022 Jul; 16(4):e2100068. PubMed ID: 35238465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and verification of coexisting diagnostic markers in plasma and serum of patients with non-small-cell lung cancer.
    Yu M; Sun R; Zhao Y; Shao F; Zhu W; Aa J
    Future Oncol; 2021 Nov; 17(32):4355-4369. PubMed ID: 34674559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of fine needle aspiration cytology and core biopsy histopathology with or without immunohistochemical staining in the subtyping of the non-small cell lung carcinomas: Experience from an academic centre in Turkey.
    Bayrak BY; Paksoy N; Vural Ç
    Cytopathology; 2021 May; 32(3):331-337. PubMed ID: 33145811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of immunohistochemical staining in diagnosing pulmonary squamous cell carcinoma.
    Yan Y; Zhang YX; Fang WF; Kang SY; Zhan JH; Chen N; Hong SD; Liang WH; Tang YN; He DC; Wu X; Zhang L
    Asian Pac J Cancer Prev; 2015; 16(2):551-7. PubMed ID: 25684486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.
    Neumann JM; Niehaus K; Neumann N; Knobloch HC; Bremmer F; Krafft U; Kellner U; Nyirády P; Szarvas T; Bednarz H; Reis H
    Lab Invest; 2021 Sep; 101(9):1281-1288. PubMed ID: 34021261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
    Esterbrook G; Anathhanam S; Plant PK
    Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Metabolomics and Machine Learning to Identify Diagnostic and Prognostic Biomarkers in Patients with Non-Small Cell Lung Cancer Pre- and Post-Radiation Therapy.
    Murcia-Mejía M; Canela-Capdevila M; García-Pablo R; Jiménez-Franco A; Jiménez-Aguilar JM; Badía J; Benavides-Villarreal R; Acosta JC; Arguís M; Onoiu AI; Castañé H; Camps J; Arenas M; Joven J
    Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Small Cell Lung Cancer Detection and Subtyping by UPLC-HRMS-Based Tissue Metabolomics.
    Zang X; Zhang J; Jiao P; Xue X; Lv Z
    J Proteome Res; 2022 Aug; 21(8):2011-2022. PubMed ID: 35856400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.
    Ağababaoğlu İ; Önen A; Demir AB; Aktaş S; Altun Z; Ersöz H; Şanl A; Özdemir N; Akkoçlu A
    Medicine (Baltimore); 2017 Feb; 96(6):e5903. PubMed ID: 28178129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.